DK3013317T3 - Silicahydrogelkomposit - Google Patents

Silicahydrogelkomposit Download PDF

Info

Publication number
DK3013317T3
DK3013317T3 DK14739213.8T DK14739213T DK3013317T3 DK 3013317 T3 DK3013317 T3 DK 3013317T3 DK 14739213 T DK14739213 T DK 14739213T DK 3013317 T3 DK3013317 T3 DK 3013317T3
Authority
DK
Denmark
Prior art keywords
silica hydrogel
hydrogel composite
composite
silica
hydrogel
Prior art date
Application number
DK14739213.8T
Other languages
Danish (da)
English (en)
Inventor
Harry Jalonen
Ari-Pekka Forsback
Mika Jokinen
Original Assignee
Delsitech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delsitech Oy filed Critical Delsitech Oy
Application granted granted Critical
Publication of DK3013317T3 publication Critical patent/DK3013317T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0063Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0073Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form semi-solid, gel, hydrogel, ointment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)
DK14739213.8T 2013-06-24 2014-06-18 Silicahydrogelkomposit DK3013317T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20135685 2013-06-24
PCT/FI2014/050492 WO2014207304A1 (en) 2013-06-24 2014-06-18 Silica hydrogel composite

Publications (1)

Publication Number Publication Date
DK3013317T3 true DK3013317T3 (da) 2020-02-17

Family

ID=51178958

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14739213.8T DK3013317T3 (da) 2013-06-24 2014-06-18 Silicahydrogelkomposit

Country Status (14)

Country Link
US (1) US9949922B2 (ja)
EP (1) EP3013317B1 (ja)
JP (1) JP6433490B2 (ja)
CN (1) CN105451713B (ja)
AU (1) AU2014300888B2 (ja)
CA (1) CA2912483C (ja)
DK (1) DK3013317T3 (ja)
ES (1) ES2768606T3 (ja)
HR (1) HRP20200134T1 (ja)
HU (1) HUE047897T2 (ja)
LT (1) LT3013317T (ja)
PL (1) PL3013317T3 (ja)
PT (1) PT3013317T (ja)
WO (1) WO2014207304A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
MX2018004797A (es) 2015-10-22 2018-09-06 Delsitech Oy Formulacion de liberacion prolongada a base de un compuesto de hidrogel.
FI20155779A (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
WO2018102480A1 (en) * 2016-11-30 2018-06-07 Brown University Methods of fabricating hyper compliant polymer particles and methods of use and compositions
EP3743112A4 (en) * 2018-01-23 2021-11-03 Ascend Biopharmaceuticals Ltd IMPROVED VIRAL RELEASE FORMULATION
JP2021531328A (ja) 2018-06-19 2021-11-18 セラ セラピューティクス エルエルシー 神経栄養剤、アポトーシスシグナリング断片化阻害剤(FAS)もしくはFASリガンド(FASL)阻害剤、腫瘍壊死因子α(TNF−α)もしくはTNF受容体阻害剤、ミトコンドリアペプチド、オリゴヌクレオチド、ケモカイン阻害剤、またはシステイン−アスパラギン酸プロテアーゼを含む薬剤送達系
CN112566622A (zh) 2018-06-19 2021-03-26 细胞疗法有限责任公司 用于治疗青光眼或高眼压症的包含眼内压降低剂、cnp化合物、npr-b化合物、tie-2激动剂或神经营养剂的缓释药物递送系统
JP7045658B2 (ja) 2018-08-08 2022-04-01 カワサキモータース株式会社 自動二輪車
KR20200051916A (ko) * 2018-11-05 2020-05-14 주식회사 메디포럼제약 고세렐린을 포함하는 실리카 하이드로겔 조성물
US11383006B2 (en) 2019-08-06 2022-07-12 Dose Medical Corporation Bioerodible cross-linked hydrogel implants and related methods of use
CN111443012B (zh) * 2020-04-09 2021-07-20 华南理工大学 基于复合波等变率温度扫描流变的聚合物凝胶点表征方法
WO2021250626A2 (en) 2020-06-12 2021-12-16 Glaxosmithkline Biologicals Sa Dock tag system
US20230248647A1 (en) * 2020-07-07 2023-08-10 Delsitech Oy Silica hydrogel composite and its use
WO2024047230A1 (en) 2022-09-01 2024-03-07 Optifye Therapeutics Ag Ophthalmic compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045367A1 (en) * 1996-05-29 1997-12-04 Orion-Yhtymä Oy Dissolvable oxides for biological applications
DE10301669A1 (de) * 2003-01-17 2004-07-29 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Bioaktive keramische Kompositmaterialien und Verfahren zu deren Herstellung
AU2005217169B2 (en) 2004-02-27 2011-09-01 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived SiO2
GB0420016D0 (en) * 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
WO2007135224A2 (en) 2006-05-23 2007-11-29 Delsitech Oy Method for storing silica-based material, package produced with the method and use of package for packaging of silica-based products
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US20090324695A1 (en) 2008-05-30 2009-12-31 Paul Ducheyne Biocompatible polymer ceramic composite matrices
KR101068873B1 (ko) 2008-11-28 2011-09-30 연세대학교 산학협력단 바이오마커가 고정된 실리카 나노입자를 함유하는 하이드로젤 및 그 제조방법
EP2483332B1 (en) 2009-09-30 2018-06-20 Ottawa Hospital Research Institute Crosslinked hydrogels and related method of preparation

Also Published As

Publication number Publication date
PT3013317T (pt) 2020-02-19
CN105451713B (zh) 2019-04-23
HRP20200134T1 (hr) 2020-08-21
US9949922B2 (en) 2018-04-24
EP3013317B1 (en) 2019-12-04
US20160136088A1 (en) 2016-05-19
EP3013317A1 (en) 2016-05-04
PL3013317T3 (pl) 2020-05-18
JP2016522243A (ja) 2016-07-28
AU2014300888B2 (en) 2019-01-17
HUE047897T2 (hu) 2020-05-28
ES2768606T3 (es) 2020-06-23
CA2912483A1 (en) 2014-12-31
CN105451713A (zh) 2016-03-30
JP6433490B2 (ja) 2018-12-05
CA2912483C (en) 2021-06-15
WO2014207304A1 (en) 2014-12-31
AU2014300888A1 (en) 2015-12-10
LT3013317T (lt) 2020-03-10

Similar Documents

Publication Publication Date Title
CL2014001353S1 (es) Neumatico
CL2014000003S1 (es) Automovil
UA28362S (uk) Автомобіль
DK3013317T3 (da) Silicahydrogelkomposit
UA28570S (uk) Автомобіль
CL2014001622S1 (es) Neumatico
CL2014000677S1 (es) Neumatico
UA28733S (uk) Автомобіль
UA30094S (uk) Автомобіль
UA29168S (uk) Автомобіль
UA28738S (uk) Автомобіль
UA29027S (uk) Автомобіль
CL2014000346S1 (es) Automovil
CL2014000155S1 (es) Automovil
UA28962S (uk) Автомобіль
UA27672S (uk) Автомобіль
TH1501002845A (th) วัตถุกระจก
UA30596S (uk) Автомобіль
CL2014000437S1 (es) Automovil
CL2014000414S1 (es) Automovil
CL2014000280S1 (es) Automovil
UA29992S (uk) Автомобіль
CL2013003733S1 (es) Automovil
UA28966S (uk) Автомобіль
UA28375S (uk) Автомобіль